Our data pave the way for new investigative experimental approaches to validate the prevention of cancer by interfering with the FAM72A-UNG2 signaling pathways using withaferin B. Withaferin B is a potential candidate for future investigations in the interference with genome stability, centromere formation, and genome editing, and on potential therapeutic strategies for the treatment of cancer. This evidence concerns the gene UNG and cancer.